ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 140 filers reported holding ACCELERON PHARMA INC in Q4 2017. The put-call ratio across all filers is 0.92 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $6,421,000 | +594.2% | 51,165 | +216.5% | 0.05% | -2.0% |
Q3 2018 | $925,000 | -41.0% | 16,167 | -50.0% | 0.05% | -62.6% |
Q2 2018 | $1,569,000 | +107.5% | 32,334 | +67.2% | 0.13% | +31.0% |
Q1 2018 | $756,000 | -20.5% | 19,334 | -13.7% | 0.10% | -25.9% |
Q4 2017 | $951,000 | – | 22,400 | – | 0.14% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Novo Holdings A/S | 1,103,937 | $53,563,000 | 5.39% |
GREAT POINT PARTNERS LLC | 758,000 | $36,778,000 | 5.10% |
Foresite Capital Management II, LLC | 244,756 | $11,876,000 | 4.18% |
GREAT POINT PARTNERS LLC | 552,300 | $26,798,000 | 3.71% |
Foresite Capital Management III, LLC | 278,753 | $13,525,000 | 2.91% |
QVT Financial LP | 190,977 | $9,266,000 | 2.66% |
Perceptive Advisors | 1,528,205 | $74,149,000 | 1.94% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,126,800 | $54,672,000 | 1.92% |
SECTORAL ASSET MANAGEMENT INC | 306,626 | $14,877,000 | 1.66% |
Parametrica Management Ltd | 5,645 | $274,000 | 1.30% |